Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

16 drugs in this class with 275,061 total adverse event reports.

16 Drugs
275,061 Total Reports
93,606 Serious Reports
25,615 Death Reports
# Drug Name Generic Name Reports Serious Deaths
1 Emtricitabine / Tenofovir Disoproxil Fumarate EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 45,135 19,105 1,803
2 Tenofovir Disoproxil TENOFOVIR DISOPROXIL FUMARATE 32,755 13,488 1,926
3 Lamivudine LAMIVUDINE 30,530 9,944 4,060
4 Ritonavir RITONAVIR 28,964 6,825 2,620
5 Raltegravir RALTEGRAVIR 16,361 4,410 1,621
6 Darunavir DARUNAVIR 14,955 4,418 1,491
7 Atazanavir ATAZANAVIR 14,266 2,573 1,064
8 Lopinavir / Ritonavir LOPINAVIR AND RITONAVIR 13,443 3,269 1,766
9 Zidovudine ZIDOVUDINE 13,223 3,231 1,633
10 Entecavir ENTECAVIR 11,390 4,798 1,861
11 Efavirenz EFAVIRENZ 11,033 3,364 1,527
12 Abacavir ABACAVIR SULFATE 9,609 3,283 1,172
13 Nevirapine NEVIRAPINE 8,934 2,385 1,506
14 Dolutegravir DOLUTEGRAVIR SODIUM 8,900 4,343 886
15 Cabotegravir CABOTEGRAVIR 7,871 6,927 90
16 Lamivudine / Zidovudine LAMIVUDINE AND ZIDOVUDINE 7,692 1,243 589